Investors Purchase Large Volume of Call Options on 1Life Healthcare (NASDAQ:ONEM)

1Life Healthcare, Inc. (NASDAQ:ONEM) saw unusually large options trading on Thursday. Traders bought 6,716 call options on the company. This is an increase of approximately 449% compared to the average volume of 1,223 call options.

1Life Healthcare stock opened at $12.16 on Friday. The company’s 50 day simple moving average is $17.55 and its 200 day simple moving average is $22.31. 1Life Healthcare has a fifty-two week low of $11.88 and a fifty-two week high of $59.82. The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of -10.48 and a beta of 1.47. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.58 and a quick ratio of 3.54.

1Life Healthcare (NASDAQ:ONEM) last released its quarterly earnings data on Wednesday, November 3rd. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.16). 1Life Healthcare had a negative return on equity of 20.34% and a negative net margin of 32.50%. The firm had revenue of $151.33 million for the quarter, compared to the consensus estimate of $144.97 million. During the same period in the previous year, the business earned ($0.13) EPS. As a group, analysts predict that 1Life Healthcare will post -1.58 EPS for the current fiscal year.

A number of equities analysts have commented on ONEM shares. SVB Leerink boosted their price objective on 1Life Healthcare from $22.00 to $24.00 and gave the stock a “market perform” rating in a research note on Tuesday, November 9th. Truist Securities reduced their price objective on 1Life Healthcare from $48.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, October 13th. reduced their price objective on 1Life Healthcare from $40.00 to $34.00 and set a “buy” rating on the stock in a research note on Thursday, November 4th. Zacks Investment Research lowered 1Life Healthcare from a “hold” rating to a “sell” rating in a research note on Wednesday, January 5th. Finally, Citigroup reduced their price objective on 1Life Healthcare from $46.00 to $32.00 and set a “buy” rating on the stock in a research note on Thursday, October 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $36.50.

Institutional investors have recently added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. bought a new position in 1Life Healthcare during the 2nd quarter worth approximately $46,000. FourThought Financial LLC lifted its stake in 1Life Healthcare by 43.4% in the third quarter. FourThought Financial LLC now owns 2,667 shares of the company’s stock valued at $54,000 after buying an additional 807 shares in the last quarter. Dark Forest Capital Management LP bought a new position in 1Life Healthcare in the second quarter valued at approximately $135,000. Spire Wealth Management bought a new position in 1Life Healthcare in the fourth quarter valued at approximately $78,000. Finally, Great West Life Assurance Co. Can lifted its stake in 1Life Healthcare by 33.0% in the second quarter. Great West Life Assurance Co. Can now owns 4,634 shares of the company’s stock valued at $153,000 after buying an additional 1,149 shares in the last quarter. 71.32% of the stock is currently owned by institutional investors and hedge funds.

1Life Healthcare Company Profile

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

Recommended Story: What defines an oversold asset?

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.